Yitshak Kreiss

Director General

Sheba Medical Center, FOH Founder

As Director General of Sheba Medical Center since 2016, Prof. Yitshak Kreiss is world renowned for his research in leadership and health management based on humanitarian operations he led during 25 years of service in the Israel Defense Forces (IDF). While in the IDF, he rose from combat surgeon to leadership of the Medical Corps as IDF Surgeon General and attained the rank of Brigadier General. He earned his medical degree at the Hebrew University; completed a residency in internal medicine at Sheba Medical School; and earned a Master of Health Administration from Tel Aviv University and a Master of Public Administration from Harvard University. Prof. Kreiss was cited as one of the 50 most influential Jews of 2020 by the Jerusalem Post. Under his tutelage, Sheba Medical Center has also been ranked as one of the Top 10 Hospitals in the World by Newsweek Magazine since 2019.

Dr. Fabrice Brunet, MD

President and CEO

CHUM

Dr. Brunet is the President and Chief Executive Officer of Centre Hospitalier de l’Université de Montréal (CHUM) and Centre Hospitalier Universitaire Sainte-Justine since September 3, 2015. He was the CEO of Sainte-Justine since January 3, 2009. He is also the President of the University of Montreal Health Network (RUIS). He is a Professor in the Department of Pediatrics at the University of Montreal; Professor of Medicine at the University of Toronto and the University of Paris; and Professor of Management at HEC Montreal and the Business School of Paris.

His many accomplishments include the development of a clinical research program in critical care and a cardiac surgery centre in Paris; the design of a private hospital project in Saint Petersburg, Russia; and the creation of an academic critical care department in Toronto.

Dr. Brunet completed his medical studies at the Faculty of Medicine Cochin Port Royal, the University of Paris V. He is Board certified in cardiology, intensive care, and emergency medicine. Dr. Brunet went on to complete his studies in management at Paris Business School, the Public Health School of Management at Harvard, and the University of Toronto. Until his arrival at CHU Sainte-Justine, he was the Chief of the Department of Critical Care at St. Michael’s Hospital in Toronto and the Medical Director of their Telemedicine Program. He then became President and CEO of the alliance between CHUM and CHU Sainte-Justine. He has extensive experience in clinical research, education and hospital management with numerous publications in peer-reviewed journals and chapters in textbooks. His main fields of interest are knowledge management in medicine, learning healthcare network development, and improvement in global performance.

Mr. Vincent-Nicolas Delpech

CEO

North-University of Paris Hospital Group

Since February 1, 2019, Vincent-Nicolas Delpech has been CEO of the North-University of Paris Hospital Group, which includes 7 Parisian hospitals (Saint-Louis, Lariboisière – Fernand-Widal, Bichat – Claude-Bernard, Beaujon, Louis-Mourier, Bretonneau, and Robert-Debré). These employ 20,000 health professionals.

Since May 2019, he is also the chairman of RMEF (Réseau Mère Enfants de la Francophonie).

Dr. Sunil Eappen

Chief Medical Officer And Senior Vice President For Medical Affairs

Brigham And Women’s Hospital

Dr. Eappen currently serves as the interim president of Brigham Health, a role he assumed on March 1. Additionally, Eappen serves as Chief Medical Officer, where he leads key initiatives in physician recruitment and retention, medical affairs and patient care. Partnering closely with the Associate Chief Medical Officers, he will focus on developing new clinical care delivery strategies that will significantly improve efficiency, financial outcomes and, most importantly, patient outcomes.

Eappen will lead efforts focusing on integration between Brigham Health and Mass General Brigham clinicians, pharmacy management, and nurturing a culture of professionalism that extends beyond physicians and nurses to all Brigham and Women’s Hospital staff.

Eappen joined BWH on July 16, 2018, from Massachusetts Eye and Ear Infirmary, where he most recently served as the Chief of Anesthesiology and the Chief Medical Officer. He was previously the Medical Director of the Operating Rooms at Massachusetts Eye and Ear Infirmary. In these roles at the Mass Eye and Ear, he managed the Medical Staff Office and the pharmacy as well as leading the Quality and Patient Experience Programs.

Eappen earned his bachelor’s degree in mathematics and computer science from the University of Illinois at Urbana- Champaign, his MD from the University of Chicago’s Pritzker School of Medicine and an MBA from the Yale University School of Management. He completed his residency in anesthesiology at Brigham and Women’s Hospital. Eappen has numerous published articles and is a national speaker on the utility of surgical checklist implementation in order to reduce surgical complications, optimizing OR efficiency, and change management. In addition to serving as CMO, Eappen is also an Associate Professor of Anesthesia at Harvard Medical School.

Dr. Osnat Luxenburg, MD, MPH, MBA

Director of Medical Technology, Health Information and Innovation

Israeli Ministry of Health

Dr. Osnat Luxenburg is the Director of the Medical Technology, Health Information, Innovation and Research Directorate at the Israeli Ministry of Health. In this role, she is responsible for the regulation and licensing of all medical technologies including – pharmaceuticals, biological products, medical devices, procedures etc. She is in charge of decision-making on reimbursement at a national level (health services to be included under the National Insurance Law). Her other roles include – licensing all the hospitals and other medical facilities in Israel, the regulation of radiation protection in Israel and formulating national health policy.

The Directorate is also responsible for the health information in the Ministry including national data gathering as well as national registries such as the cancer registry. Another main activity is supporting research on a national level and promoting innovation in the biotech field in Israel.

Dr. Stephen Klasko, MD, MBA

Executive In Residence

General Catalyst

Dr. Stephen Klasko is a transformative leader and advocate for a revolution in our systems of healthcare and higher education. In 2020, he published “UnHealthcare: A Manifesto for Health Assurance” in which he and Silicon Valley’s Hemant Taneja describe a new future for healthcare focused on keeping people well.

As President of Philadelphia-based Thomas Jefferson University and CEO of Jefferson Health, he has steered since 2013 one of the nation’s fastest growing academic health institutions based on his vision of reimagining health care and higher education. His 2017 merger of Thomas Jefferson University with Philadelphia University creates a pre-eminent professional university that includes top-20 programs in fashion and design coupled with the first design thinking curriculum in a medical school and the nation’s leading research on empathy.

His track record of success at creating and implementing programs that are shaping the future of health care earned him a place among Fast Company’s 100 Most Creative People in Business in 2018 and Ernst & Young’s Greater Philadelphia Entrepreneur of the Year in 2018. He is also ranked #2 on Modern Healthcare’s list of Most Influential People in Healthcare. For 2018 to 2019, U.S. News & World Report ranked Thomas Jefferson University Hospital among the nation’s best in 10 specialties, and Magee Rehabilitation Hospital – Jefferson Health 13th Best Hospital in the nation for physical rehabilitation. In 2018, Jefferson was invited to join the World Economic Forum.

He is married to Colleen Wyse, a fashion leader and founder of The Philadelphia Trunk Show, and has three children: Lynne, David and Jill.

Prof. Christoph A. Meier, MD

Director

Department of Internal Medicine at University Hospital Zurich

Prof. Christoph A. Meier is currently the Director of the Department of Internal Medicine at the University Hospital Zurich. He heads the expert panel of the Swiss Medical Board for health technology assessments, is a member of the Federal Committee for Quality and serves on the Board of the Novartis Venture Fund.

Prior to his current role, he was from 2016 until 2020 the Chief Medical Officer and deputy CEO at the University Hospital Basel, where he implemented VBHC as a management tool, including PROMs as key tools for quality management. Before 2016 he was the Chief of the Department of Internal Medicine & Specialties and a member of the Board of Directors at Triemli Hospital in Zurich, Switzerland, as well as Chief of Endocrinology and Head of the Laboratory of Molecular Endocrinology at the University Hospital Geneva.

Prof. Meier received his Medical Degree from the University of Basel in Switzerland and holds his Swiss Board Certification (FMH) in Internal Medicine and Endocrinology & Diabetology. He completed his medical residency at the University Hospital of Geneva and was a Postdoctoral Fellow at the National Institutes of Health in the Molecular, Cellular Nutritional Endocrinology Branch in Bethesda, MD (USA). Prof. Meier was also a Howard Hughes Medical Institute Physician Fellow at the Division of Genetics, Brigham and Women’s Hospital, as well as a Clinical Fellow in Endocrinology, Diabetes and Metabolism at the Massachusetts General Hospital, Harvard Medical School.

Mr. Cameron Love, MHA

President and Chief Executive Officer

The Ottawa Hospital

Cameron Love is the President and Chief Executive Officer of The Ottawa Hospital (TOH), one of Canada’s leading academic health sciences centers. He took on this leadership role as of July 1, 2020, in an unprecedented time as Ontario’s health system adapts to a new service model in the wake of COVID-19.

Cameron is an inspirational leader, dynamic and engaging, who leads through collaboration and mutual respect. He is determined to continue building TOH’s reputation as a global leader in healthcare, research, and education, while improving the lives of people in the community, province, and country. In his mandate as CEO, Cameron aims to advance the programs and services at TOH; to help innovate new deliveries of healthcare by empowering TOH clinical teams and scientists; and to partner with patients and families in the Champlain region to deliver the best care.

The hospital’s core values of ‘Compassion, Teamwork, Commitment to Quality and Respect for the Individual,’ are bolstered by Cameron’s passion and integrity, which he has applied in the healthcare sector since 1998. Cameron served on TOH’s transitional leadership team that guided the merger of five local hospitals, leading to the creation of TOH and the integration of its programs and services across several campuses. Cameron has a Master’s in Health Administration, and training at the Wharton and Telfer Schools of Business, as well as a bachelor’s degree in Biology and Psychology. In addition, Cameron is involved in many regional and provincial initiatives, committees, and task forces, and sits on several boards that promote the health and wellbeing of the people in the region. Away from his professional life, Cameron can be found coaching his children’s minor hockey teams, downhill skiing, mountain biking, and spending time with his family.

Dr. Gary Kaplan, MD, FACP, FACMPE

Immediate Past CEO Virginia Mason
Member Board Of Stewardship Trustees
Common Spirit Health

Virginia Mason Franciscan Health, CommonSpirit

Gary S. Kaplan, MD, FACP, FACMPE, FACPE, is currently CEO, Virginia Mason Franciscan Health & Senior Vice President, CommonSpirit. Dr. Kaplan served as chairman and CEO of the Virginia Mason Health System from 2000 to January 2021. He is also a practicing internal medicine physician at Virginia Mason.

Dr. Kaplan received a degree in medicine from the University of Michigan and is board certified in internal medicine. He is a Fellow of the American College of Physicians (FACP), the American College of Medical Practice Executives (FACMPE) and the American College of Physician Executives (FACPE). He is recognized as one of the most influential physician executives in health care.

Dr. Kaplan is chair of the National Patient Safety Foundation Lucian Leape Institute, and a past chair of both the Institute for Healthcare Improvement Board of Directors and the Seattle Metropolitan Chamber of Commerce. He was a founding member of Health CEOs for Health Reform and has held leadership positions with numerous organizations, including the Medical Group Management Association and the Washington Healthcare Forum.

During Dr. Kaplan’s tenure, Virginia Mason has received significant national and international praise for its efforts to transform health care, most notably as the leader in adapting the Toyota Production System for health care. Virginia Mason has consistently been named a Top Hospital by Leapfrog and was the Top Hospital of the Decade in 2010. In addition, Virginia Mason is the only Washington state hospital to earn an A patient safety grade every year since the grading system began.

Mrs. Phoebe Yang, JD

Board Director, CommonSpirit Health, Doximity Inc.(NYSE: DOCS), GE Healthcare (NASDAQ: GEHC) (Upon Jan 2023 Spinoff)

Amazon Web Services – Healthcare

Ms. Yang is General Manager of Amazon Web Services for Healthcare. Having served in C-suite and governance roles for two other national faith-based health systems, she is committed to the mission of accessible, affordable, equitable, and excellent care. She has extensive expertise in population health, digital media, M&A and post-merger integration, and new ventures.

She served as Managing Director at Rock Water Ventures, LLC. Phoebe Yang has over 20 years of experience in digital media and health, particularly building provider-led, consumer-centric business models in complex environments for both independent and strategically embedded start-ups within both media and healthcare industries. Businesses she has built and scaled include:

Scaling a population health company to launch in 5 new markets in 18 months, covering 250,000 lives, $1.5 billion in managed care spend, and over 15,000 providers, where she also negotiated and closed the first full risk contract with a national payer.

Creating and building international supply chain business to create a global group purchasing organization that spans 7 countries in 4 continents, and projected and on track to create at least $200 million in economic value in 3 years. Leading a turn-around of a $100 million media business focused on health and wellness, including digital platforms, to unprecedented profitability after 10 years of negative OCF. Launching two new international joint ventures to provide digital services to consumers in highly regulated markets. Her previous affiliations include AOL Time Warner, Discovery Inc., Rock Water Ventures, The Advisory Board, the Federal Communications Commission, Ascension, MissionPoint Health Partners, Providence-St. Joseph Health. She is a Phi Beta Kappa graduate of the University of Virginia and Stanford University.

Dr. Lawrence Rosenberg, MD, PhD, MSc.

President and CEO

Integrated Health and Social Services at University Network, West-Central Montreal Health

Dr. Lawrence Rosenberg is President and CEO of the Integrated Health and Social Services University Network for West-Central Montreal (West-Central Montreal Health). Before assuming this position on April 1, 2015, Dr. Rosenberg had served since 2013 as Executive Director of the Jewish General Hospital (JGH). After joining the hospital in 2007, he spent six years as the Chief of Surgical Services.

Dr. Rosenberg is Professor of Surgery and Medicine at McGill University, where he earned a Master of Science degree and a doctorate in experimental surgery. He also completed post-doctoral studies and a surgical fellowship in transplantation at the University of Michigan, and went on to earn a Master of Engineering degree—the equivalent of an MBA for scientists and engineers—from the University of Waterloo.

Before coming to the JGH, Dr. Rosenberg served as Director of the Multi-Organ Transplant Program at the Montreal General Hospital, inaugurating McGill’s Pancreas Transplant Program and leading the team that performed the first successful liver transplant at McGill.

A widely acknowledged expert in the field of islet cell regeneration, Dr. Rosenberg has received many career awards, including a Chercheur National Award from the Government of Quebec. He remains the only Canadian to have received the prestigious American Surgical Association Foundation Fellowship, and he has served as a consultant to the Juvenile Diabetes Research Foundation, the Canadian Diabetes Association, the Canadian Institutes for Health Research, and the National Institutes of Health.

Dr. Kevin Tabb, MD

President and CEO

Beth Israel Lahey Health

As President and Chief Executive Officer of Beth Israel Lahey Health (BILH), Kevin Tabb, MD, is responsible for leading a comprehensive integration plan among the BILH member organizations to effectively deliver on the promise to offer patients and their families better and broader access to extraordinary individualized care. Previously, Kevin was the Chief Executive Officer of the Beth Israel Deaconess system and Beth Israel Deaconess Medical Center (BIDMC).

Before coming to BIDMC, Kevin was Chief Medical Officer at Stanford Hospital & Clinics in Stanford, California. There, he had broad strategic and operational responsibilities, which included physician network strategy, clinical quality and patient safety initiatives, regulatory and medical staff affairs, and graduate and continuing medical education. He was previously Chief Quality and Medical Information Officer at Stanford. Prior to joining Stanford, Kevin led the Clinical Data Service Division of GE Healthcare IT.

Raised in Berkeley, California, Kevin emigrated to Israel at the age of 18 and served in the Israel Defense Forces, the country’s military service. He received his undergraduate degree from Hebrew University in Jerusalem and his MD from the Hebrew University Hadassah Medical School. He completed his residency in internal medicine at Hadassah Hospital.

Kevin resides with his family in Newton.

Dr. David Bates, MD, MS

General Internal Medicine Chief

Brigham & Women’s Hospital

Dr. Bates is an internationally renowned expert in patient safety, using information technology to improve care, quality-of-care, cost-effectiveness, and outcomes assessment in medical practice. He is a Professor of Medicine at Harvard Medical School and a Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health, where he co-directs the Program in Clinical Effectiveness. He directs the Center for Patient Safety Research and Practice at Brigham and Women’s Hospital and serves as external program lead for research in the World Health Organization’s Global Alliance for Patient Safety.

He is the immediate past president of the International Society for Quality in Healthcare (ISQua) and the editor of the Journal of Patient Safety. He serves as the principle investigator of the Health Information Technology CERT. He has been elected to the Institute of Medicine, the American Society for Clinical Investigation, the Association of American Physicians, and the American College of Medical Informatics. Furthermore, he was chairman of the Board of the American Medical Informatics Association. He has published over 700 peer-reviewed papers and has an h-index of 115, which ranks him among the 400 most cited biomedical researchers of any type.

Dr. Scott Dulchavsky, MD

Chief of Surgery and CEO of the Innovation Institute

Henry Ford Health System

Dr. Dulchavsky is currently a professor of surgery, molecular biology, and genetics at Wayne State University School of Medicine. He serves as the Roy D. McClure Chairman of Surgery and the Surgeon in Chief at Henry Ford Health System in Detroit, Michigan as well as the CEO of The Innovation Institute at Henry Ford Hospital.

He completed a PhD in Molecular Biology and Genetics at Wayne State University, where he investigated the use of gene therapy to improve wound healing in disease states. He also has served as research mentor to over 20 post-doctoral fellows and is a principal investigator for NASA and for the National Space Biomedical Research Institute in Houston, Texas. His research focus involves teaching ultrasound to the astronaut and cosmonaut crews of the International Space Station to use for medical emergencies and on medical care of exploration class spaceflight.
Dr. Dulchavsky has been elected to numerous professional organizations and national positions, including the Society of University Surgeons, Society of Critical Care Medicine, Central Surgical Society, American Association for the Surgery of Trauma, the Society of Clinical Surgery, and the American Surgical Association. He is on the White House Medical Team that provides regional care for the President of the United States.

SUJA MATHEW

CEO

Atlantic Health System

Suja Mathew, MD, FACP was appointed as EVP, Chief Clinical Officer at Atlantic Health System in March, 2022. She oversees the quality, education, research and health equity missions of the organization and collaborates to drive system clinical strategy.

Prior to joining AHS, Dr. Mathew had a long career at Cook County Health in Chicago, Illinois where she served most recently as System Chair of Medicine, responsible for all aspects of internal medicine, neurology, and dermatology services across the health system.

Dr. Mathew holds several influential leadership roles nationally. She is a Regent of the American College of Physicians and chair of the society’s national health and public policy committee, where she has authored several key position papers that guide the practice of medicine. She also serves on the ACP governance committee, the ACP performance measurement committee, and the American Medical Association House of Delegates. She is also an elected member of the AMA’s Council on Medical Education.

Dr. Mathew is a board-certified internal medicine physician. She completed medical school at the Pritzker School of Medicine with AOA honor and residency training at the University of Chicago Hospitals. Dr. Mathew has particular interest in the areas of social determinants of health, nutrition insecurity, and health equity. She co-chairs Doctors for a Hunger Free America. Dr. Mathew is an awarded teacher, mentor, and leader and a recognized humanitarian.

Dr. Alan Forster, MD

Executive Vice President, Chief Innovation and Quality Officer

The Ottawa Hospital

Dr. Alan J. Forster MD, FRCPC, MSc is a general internist; Vice President, Innovation and Quality at the Ottawa Hospital; Vice Chair, Quality and Clinical Services, Department of Medicine, Faculty of Medicine, University of Ottawa. He is a Professor of Medicine at the University of Ottawa and Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute.

His research focuses on patient safety and quality improvement. He has performed seminal work evaluating the incidence of adverse events following discharge from the hospital. This work has to lead to the development of strategies to improve care during the transition home from the hospital. He is also leading in the development of a hospital data warehouse, which will serve as a supporting infrastructure for a research program in patient safety and quality of care. He has over 160 publications in peer review journals. He has served as associated editor for several prestigious peer-review journals.

He has received several prestigious awards recognizing his work within the field of health services research, including a Career Scientist Award with the Ontario Ministry of Health and Long-Term Care and an Early Research Award and Ontario Research Fund grant from the Ontario Government’s Ministry of Research and Innovation. In addition to his significant contributions to a quality and safety program at the Ottawa Hospital, he provides ongoing scientific advice regarding the measurement of quality of care to national and international organizations, such as the Canadian Institute for Health Information, eHealth Ontario, Health Quality Ontario and the World Health Organization.

Susan E. Sheridan, MIM, MBA, DHL, is a Founding Member of Patients for Patient Safety (PFPS) US and the Director of Patient Engagement Emeritus at the Society to Improve Diagnosis in Medicine (SIDM). In 2022, Sheridan was appointed to the Patient Safety Working Group of the President’s Council of Advisors on Science and Technology (PCAST). Prior to her current roles, she served as the Patient and Family Engagement Adviser in the Center for Clinical Standards and Quality at the Centers of Medicare and Medicaid Services (CMS), the Director of Patient Engagement of the Patient-Centered Outcomes Research Institute (PCORI) and led the World Health Organization’s (WHO) Patients for Patient Safety initiative, a program under the World Health Organization (WHO) Patient Safety Program. Sheridan is also a member of the Institute of Healthcare Improvement Lucian Leape Institute, a think tank of international thought leaders that provides strategic vision for improving patient safety.

Sheridan had previously spent 10 years in patient advocacy inspired by adverse family experiences in the healthcare system. Sheridan is Co-Founder and Past President of Parents of Infants and Children with Kernicterus (PICK) as well as Consumers Advancing Patient Safety (CAPS).

In April 2009, Sheridan was named to Modern Healthcare’s list of Top 25 Women in Healthcare as well as Modern Healthcare’s 100 Most Powerful People in Healthcare. In 2011 Sheridan was appointed by The Secretary of Health and Human Services to serve on the Advisory Committee on Infant Mortality. She also served on the Centers for Disease Control’s (CDC) CLIAC Federal Advisory Council and the Accreditation Council of Graduate Medical Education (ACGME) Board of Directors asa Public Director. In 2022 she was awarded the Mark Graber Award of Excellence by SIDM. Sheridan and her family have been featured in USA Today, Wall Street Journal and New York Times and in the international documentaries, Chasing Zero: Winning the War on Healthcare Harm and To Err is Human.

Sheridan received her BA from Albion College, her MIM and MBA from Thunderbird School of Global Management and her Honorary Doctorate of Humane Letters from Adrian College. She has a professional background in international banking and served in Ecuador with her late husband, Pat, as Peace Corps volunteers.

Dr. Mark McClellan, MD, PhD

Founding Director

Duke-Margolis Center for Health Policy at Duke University

Dr. McClellan is a doctor and an economist who has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation.

At the center of the nation’s efforts to combat the pandemic, Dr. McClellan is the co-author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country. His current work on responding to the COVID-19 public health emergency spans virus containment and testing strategies, reforming health care toward more resilient models of delivering care, and accelerating the development of therapeutics and vaccines. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. He also has a highly distinguished record in public service and academic research.

Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.

Dr. Ryan Noach, MD

Chief Executive Officer

Discovery Health

Dr. Ryan Noach is the Chief Executive Officer Discovery Health, appointed to this role in January 2020 after serving as Deputy CEO in the business for more than 5 years. Ryan joined Discovery Health in 2008 in the provider relations area, and became Chief Operating Officer of Discovery Health in 2009. During 2018 and 2019, Ryan was seconded to Discovery Bank, in the capacity of Deputy CEO of the Bank, to support the Banking team through the product finalization, build completion, business readiness and launch period. Ryan was previously the Chief Operating Officer and an Executive Director of the Netcare Hospital Group, having held various leadership roles across Netcare. His exposure to leadership in both the funding and provider sides of private healthcare, as well as more broadly in Banking and payments, unlocks useful insights.

Ryan qualified as a medical practitioner at Wits University in 1997 and pursued a post-graduate career in emergency medicine and disaster management. He completed the Diploma in Primary Emergency Care and attended the Executive Development Program at GIBS Business School, University of Pretoria.

Ryan thoroughly enjoyed his exposure to Banking, maximizing the opportunity to learn a new field, and gain new skills, whilst leveraging his leadership and operational experience to contribute to the Bank.

Ryan has been consistently involved in various social and entrepreneurial causes throughout his adult life. Ryan is a proud father of 4 beautiful children, and in keeping with the Discovery Vitality culture, is an exercise and healthy nutrition fanatic.

DR. JON PERLIN MD, PHD, MSHA, MACP, FACMI

President & CEO

The Joint Commission

Jonathan B. Perlin is President, Clinical Operations and Chief Medical Officer, HCA Healthcare, where he leads clinicians, data scientists, and researchers in using a learning health system model for improving care at the system’s 185 hospitals and 2,200 sites of care. His team’s work has achieved national recognition for preventing elective preterm deliveries, reducing maternal mortality, increasing sepsis survival, and developing public-private-academic partnerships for improving infection prevention and treating COVID-19. Their implementation of the ”Surviving Sepsis Campaign” and a computerized algorithm has saved over 8,000 lives and was recognized as the 2019 Red Hat Innovation of the Year and also earned the John M. Eisenberg Award for National Innovation in Patient Safety. In 2021, Perlin launched the “Consortium of HCA Healthcare and Academia for Research Generation” in partnership with the Agency for Healthcare Research and Quality and multiple universities (Columbia, Cleveland Clinic, Duke, Harvard, Meharry, UMass, UCSF) to accelerate the understanding of COVID-19 and its treatment as well as to create a platform for agile research partnerships.

Prior to HCA, Dr. Perlin was Under Secretary for Health in the U.S. Department of Veterans Affairs. He is a MedPAC Commissioner; a Congressional Budget Office Health Advisor; chairs the National Quality Forum and the VA Special Medical Advisory Group; and is an elected member of the National Academy of Medicine. He serves on the Board of Meharry Medical College and has faculty appointments at Vanderbilt University as Clinical Professor of Medicine and Biomedical Informatics and at VCU as Adjunct Professor of Health Administration.

Dr. David Rhew, MD

Chief Medical Officer and Vice President

Healthcare Microsoft

Dr. David Rhew joined Microsoft’s Worldwide Commercial Business (WCB) Healthcare leadership team as the Chief Medical Officer and Vice President of Healthcare.

David joined from Samsung, where he spent six years leading the company’s healthcare efforts as Chief Medical Officer and Vice President for Enterprise Healthcare. He was recently named one of Modern Healthcare’s 50 Most Influential Clinical Executive Leaders, and also serves as an adjunct professor at the Stanford University School of Medicine.

In addition, David is a computer scientist who holds six U.S. patents related to clinical decision support systems and the interoperability and integration of data in electronic health records (EHRs). An internationally recognized digital health thought leader, David has been a driving force behind the development, validation, and deployment of digital health solutions recognized by global organizations such as the Consumer Technology Association and the Vatican’s Pontifical Council for Culture as being some of the most innovative and impactful in the industry.

David provides executive-level support, engaging in business opportunities with our customers and partners. In addition, David represents the company within the marketplace through industry events and engagements. With his cross-discipline expertise and his keen ability to engage, listen, and collaborate, David’s work with our customers and partners will ensure that Microsoft delivers the right technologies and capabilities to reimagine the industry.

Dr. Elizabeth Fowler is Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation at CMS. Dr. Fowler previously served as Executive Vice President of programs at The Commonwealth Fund and Vice President for Global Health Policy at Johnson & Johnson. Before that, she was special assistant to President Obama on health careand economic policy at the National Economic Council. From 2008 to 2010, she was Chief Health Counsel at the Senate Finance Committee, where she played a critical role developing the Senate version of the Affordable Care Act. She also played a key role drafting the 2003 Medicare Prescription Drug, Improvement and Modernization Act (MMA). Dr. Fowler has over 25 years of experience in health policy and health services research. She earned a bachelor’s degree from the University of Pennsylvania, a Ph.D. from the Johns Hopkins Bloomberg School of Public Health, and a law degree (J.D.) from the University of Minnesota. She is admitted to the bar in Maryland, the District of Columbia, and the U.S. Supreme Court. Dr. Fowler is a Fellow of the inaugural class of the Aspen Health Innovators Fellowship and was elected to the National Academy of Medicine in 2022.

Björn Zoëga, MD, PhD

CEO

Karolinska University Hospital

Dr. Björn Zoëga has served as the CEO at Karolinska University Hospital in Sweden since April 2019.

Other roles that he has had are CEO of the GHP Spine Center in Sweden; COO of NextCode Health; and CEO and COO of Landspitali University Hospital in Iceland.

By training, he is an orthopedic surgeon and obtained his degree from Sahlgrenska University Hospital in Sweden.

Mr. Eric Larsen

President

Advisory Board Company

Eric Jon Larsen serves as President of The Advisory Board Company, a best practices firm dedicated to improving the performance of healthcare organizations around the world.

Eric has oversight responsibility for enterprise strategic relationships, key client partnerships and companywide business growth efforts. He is a leading national expert on healthcare market forces and industry transformation and has served as a trusted strategic advisor to
the CEOs of health systems, payers, pharmaceutical companies, physician groups, and digital-forward startups – both domestic and international – for more than two decades. Eric is a frequent conference speaker, writes extensively on healthcare dynamics, and helps
guide the work of our best practice research experts studying the future of health care.

In addition, Eric profiles the industry’s preeminent healthcare leaders in his published series, “Lessons from the C-Suite,” which is distributed to a readership of 250,000. These conversations explore the personal and professional journeys of healthcare’s most influential CEOs, and their forward-looking approaches to industry issues of national importance. To date, he has published more than 50 of these conversations, and the majority of his CEO participants are perennial members of Modern Healthcare’s “100 Most Influential People in Healthcare.”

Eric received his bachelor’s degree from Georgetown University’s School of Foreign Service in 1995. In addition to his work with The Advisory Board, Eric serves on the Boards of Directors of several organizations, including The Washington National Opera (where he
serves as chairman of the board) and The Washington Ballet. Eric also serves on the Board of Directors for Mytonomy, a patient experience cloud company; Contessa Health, a home recovery care organization that offers acute care, post-acute care, and surgical procedure services; and Somatus, a leading provider of value-based kidney care for health plans, health systems, and provider groups.

Eric is an enthusiastic traveler, having visited 95 countries across all seven continents. He lives in Washington, DC with his wife, Susi, and their three children.

DR. MAURICE GOODMAN, MD, MBA

Chief Medical Officer

Discovery Health

After obtaining his medical degree, Dr. Goodman worked for several years in emergency medicine and trauma surgery. He participated in the South African rescue missions to Phuket and Haiti.

Having completed his MBA, Dr. Goodman headed up the Southern Africa healthcare practice of a leading international consulting organization before moving into the healthcare funding industry. Dr Goodman joined Discovery Health shortly after its inception and is currently the Chief Medical Officer of Discovery Health.

Dr. Goodman is a Trustee of the Discovery Foundation which is investing in excess of R300 million into the training of medical specialists in South Africa in identified areas of need. He is also a Trustee of the Discovery Fund which is dedicated to improving individuals’ quality of life through the provision of primary health care services in indigent communities.

Dr. Goodman serves on the Executive Committees of the Wits Business School Association and the Medical Advisors Group. He is the current Vice-Chair and Immediate Past Acting President of Convocation of the University of the Witwatersrand (Wits). He also serves on the Wits Council. Dr. Goodman is a Branch Counsellor on the SA Medical Association South Gauteng Branch. He is also a Member of the SAMA Human Rights, Law and Ethics Committee.

DARYL TOL

Head of Health Assurance Ecosystem

General Catalyst

Daryl Tol served for two decades in the C suites of regional and national healthcare organizations, yet he describes his favorite work as helping patients find services they lack, new forms of advocacy, and enhanced transparency. He sees Health Assurance as a fundamental formula for human thriving – meaning there are many levers for reducing friction, inefficiency, and cost while increasing innovation, collaboration, and effectiveness of care.

At Advent Health, where he ran one of the largest hospital systems in the US, Daryl’s focus included identifying the frustrations patients should never endure, and then recasting them as a set of positive experiences patients should come to expect. With his national perspective embracing people, facilities, science, technology, finance, policies and payments, he convened the conversations necessary for advancing this mission.

Daryl leads General Catalyst’s Health Assurance Ecosystem, which aims to merge the best ideas, processes and technologies from emerging entrepreneurs and forward-thinking healthcare systems. His role is to help develop a number of model transformations with healthcare organizations that prove the health assurance thesis: Healthcare can deliver better outcomes at lower costs while attracting new talent and investment to one of the most important and vibrant industries in the world.

Away from work, Daryl gets outdoors, preferably on the water or a mountain, or he travels to immerse himself in foreign cultures. He continues to advise the pioneering mental health non-profit One Mind, focusing on global efforts around improving mental health in the workplace.

Susan Edgman-Levitan, PA, is Executive Director of the John D. Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital, a lecturer in the Department of Medicine, Massachusetts General Hospital (MGH), an Associate in Health Policy, Harvard Medical School, and an Instructor at the Harvard Chan School of Public Health. The Stoeckle Center is deeply involved in leading primary care transformation across the Partners Healthcare System in New England, now known as Mass General Brigham. Prior to MGH, Susan was the founding Presidentof the Picker Institute. A constant advocate of understanding the patient’s perspective on healthcare, she has been a principal investigator on the Yale/Harvard Consumer Assessment of Healthcare Providers and Systems (CAHPS)study and is a member of the Lucian Leape Institute and a Senior Fellow at the Institute for Healthcare Improvement (IHI). She is an editor of Through the Patient’s Eyes, a book on creating and sustaining patient-centered care, The CAHPS Improvement Guide, and co-authored the Institute of Medicine 2006 report, The Future of Drug Safety: Promoting and Protecting the Health of the Public. She is a founding member of the MA Primary Care Alliance for Patients, a statewide coalition working with the MA state legislature to fund enhanced payments for primary care services and to support practices that are at risk because of the COVID pandemic. She also co-chairs the MassGeneralBrigham Patient Experience Leaders Committee. Ms. Edgman-Levitan is also a member of the Beryl Institute’s Global Steering Committee to Co-Design the Future of PatientExperience Measurement. Ms. Edgman-Levitan serves on several boards and national advisory committees, including the AHRQ National Advisory Council, the ABIM Foundation, and the Primary Care Collaborative. In 2007, she received the Leadership and Innovation Award from the Center for Information Therapy and the 2016 Inaugural Richard Nesson award from the Massachusetts Health Quality Partnership. In 2020 she received the Partners Healthcare System Nesson award for System Collaboration. Susan holds degrees from the University of Michigan and the Duke University Physician Assistant program, where she received the Distinguished Alumni Award and was inducted into the Duke University Medical Center Hall of Fame in 2004.

Joe is an interventional cardiac electrophysiologist, medical technology expert, an experienced CEO, investor, and board member with a distinguished 25+ year career in healthcare, spanning applied research, clinical practice, medical technology innovation, national and international thought leadership, large and small company leadership, and healthcare policy.

Joe was trained as a clinician scientist in Boston, with research training at MIT and Harvard, and clinical training at Harvard Medical School and Brigham and Women’s Hospital.  His doctoral dissertation spawned a new field of scientific inquiry into mechanisms of cardiac arrhythmias as well as a new company that progressed to its own IPO.  

After additional subspecialty training in cardiology and interventional cardiac electrophysiology, Joe joined the faculty of Washington University in St. Louis in both Medicine and Biomedical Engineering, excelling in both clinical practice as well as new technology creation. Joe joined the Medical Advisory Board of Guidant Corporation in St. Paul and was subsequently recruited to be its Chief Medical Officer. Joe personally drove the US CMS positive national coverage decision for Guidant’s defibrillator therapy, driving clinical adoption of life-saving technology and associated market value growth. 

Following the Guidant Corp sale to Boston Scientific, Joe accepted a position at J&J, ultimately responsible for its Emerging Technologies organization within the Corporate Office of Science and Technology. In this role and as medical liaison to J&J’s Development Corporation, Joe identified and championed the investment and acquisition of new technologies / businesses for J&J.   

in Joe’s most recent roles, he has worked closely with Gary West, an entrepreneurial billionaire philanthropist in San Diego, in his efforts to drive efficiency into the US healthcare system.  Joe has served as Chief Medical and Science Officer for the West Health Institute, Manager of the West Health Investment Fund, Board Member of the West Health Incubator, President of the West Health Policy Center, and leadership of two digital health / virtual healthcare companies (President and CEO of Reflexion Health, Inc, and Board Chair and interim CEO of The Learning Corp, Inc). Following the successful sale of these two digital health companies, Joe joined BD as its Chief Scientific Officer, where he works across the many separate business units to identify, develop, and scale transformational medical technology solutions. 

Joe holds degrees from Johns Hopkins (B.E.S.), MIT (S.M. in Electrical Engineering; Ph.D. from the Harvard-MIT Division of Health Sciences and Technology) and Harvard Medical School (M.D.). Joe has dozens of publications and 11 patents in the field of medical technology.  He is an advisor to Johns Hopkins School of Medicine (where he also holds an adjunct faculty appointment) the Harvard-MIT Division of Health Sciences and Technology, and he serves as an advisor/board member to a number of early-stage med-tech companies.

DALE FISHER

Chief Executive Officer

Silverchain

BB(BA), MBA
Fellow & Adj Prof, Monash University
Adj Prof (Research) Swinburne University
Registered Nurse

Dale is the Chief Executive of Silverchain, Australia’s leading in-home carespecialist, providing complete health and aged care services to more than 105,000 clients a year and employing more than 4,400 people.

With a national service offering, Silverchain aims to revolutionise the way care is provided and to transform the way it is received. Guided by its ownworld class research, Silverchain is the national leader in the provision of comprehensive care at home.

Prior to joining Silverchain, Dale was the Chief Executive of Peter MacCallum Cancer Centre, establishing Peter Mac as Australia’s largest cancer centre and a world leader in translational cancer research.

Dale was also previously the Chief Executive of the Royal Women’s Hospital in Victoria, where she re-established the identity of the Women’s as a standalone specialist hospital.

Dale is an Adjunct Professor in the School of Public Health and Preventative Medicine at Monash University, and an Adjunct Professor at Swinburne University (Research).

THOMAS M. PRISELAC

President and CEO

Cedars Sinai Health System

Thomas M. Priselac has served as President and CEO of Cedars-Sinai since 1994 and was also named President and CEO of the Cedars-Sinai Health System when it was formed in 2017.

The Cedars-Sinai Heath System includes the nationally recognized Cedars-Sinai Medical Center and its affiliated physician network, major programs in physician and health professions education and the highly regarded Burnes and Allen Medical Research Institute. The Health System also includes the Cedars-Sinai Marina Del Rey Hospital; Torrance Memorial Medical Center and its affiliated physician network, the leading healthcare organization serving Torrance and the beach cities of Los Angeles; and Huntington Hospital and its affiliated physician network, the leading healthcare organization serving Pasadena and the San Gabriel Valley of Los Angeles. Through the Cedars-Sinai Medical Center, the Health System is also a joint venture partner with Select Medical in the California Rehabilitation Institute, and the Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California.

Throughout his career, Mr. Priselac has been a leader in the development of strategic and operational innovations to foster high quality, safe and efficient healthcare. An author and invited speaker on policy issues regarding the delivery and financing of healthcare, Mr. Priselac has served the health care field in various roles during his career at Cedars-Sinai. He is a past Chair of the American Hospital Association Board of Trustees and past Chair of the Association of American Medical Colleges. The holder of the Warschaw/Law Endowed Chair in Healthcare Leadership at Cedars-Sinai Medical Center, Mr. Priselac also serves as an adjunct professor at the UCLA School of Public Health.

A native of Pennsylvania, Mr. Priselac obtained a bachelor’s degree in Biology from Washington and Jefferson College in Pennsylvania, and a master’s in Public Health, Health Services Administration and Planning, from the University of Pittsburgh.

DR. STEPHEN DAVIS

President and CEO

Cincinnati Children’s Hospital Medical Center

Steve Davis, MD, has been president and CEO of Cincinnati Children’s Hospital Medical Center since November 22, 2021. He previously served six years as chief operating officer.

Dr. Davis was the driving force behind the medical center’s largest expansion ever, a $600 million Critical Care Building that opened in 2021 for patients with cancer, heart ailments, or other complex conditions. It also features a state-of-the-art emergency department, which serves Cincinnati and surrounding neighborhoods.

Cincinnati Children’s, a $2.7 billion nonprofit with a workforce of 16,500, is the region’s largest hospital system and second-largest employer. The 1.5 million patient encounters in fiscal 2020-21 benefited kids from all 50 states and 32 countries, including children with complex or rare disorders. As the medical center approaches its 150th birthday in 2033, Cincinnati Children’s is dedicated to “Pursuing Our Potential Together, So All Kids Can Pursue Theirs” – a long-range plan that elevates and accelerates care, cure, community, and cultural aspirations.

“I see my job as helping to put everybody in the organization in the best position possible to take great care of our patients, to continue learning and teaching, and to do the research that will benefit kids in the future,” Dr. Davis said. “I am an absolutely tireless advocate for kids and will always be. One thing I’ve learned over the years is that you have to create an environment that’s a great place to work so that people can put their best foot forward.”

In 2021, Cincinnati Children’s was recognized by Forbes as No. 38 among America’s Best Employers across all industries. And for more than a decade, Cincinnati Children’s has ranked among the Top 5 in U.S. News & World Report’s survey of Best Children’s Hospitals.

Cincinnati Children’s is among top recipients of pediatric research grants bestowed by the National Institutes of Health. Sponsored awards to the medical center total more than $240 million annually, with the majority coming from the NIH. Nearly one-third of employees at Cincinnati Children’s are engaged in scientific research. Philanthropy to boost research and patient care averages nearly $50 million annually.

“At Cincinnati Children’s, our people have the expertise, dedication, and heart to transform child health,” Dr. Davis said. “Our clinical excellence, focus on safety and improvement, and deep research experience is unmatched. Our collaborative spirit provides the space for each of us to learn, grow, and thrive.”

Before joining Cincinnati Children’s, Dr. Davis was chief operating officer of Hillcrest Hospital, a 500-bed facility with 2,500 employees that is part of the Cleveland Clinic system. Dr. Davis served the Cleveland Clinic in a variety of key positions from 1996 to 2015.

A pediatric critical care physician, Dr. Davis came to Cincinnati Children’s in 2015 because he wants to change the world of healthcare – for children in Cincinnati and beyond. “I envision a world where all children can reach their full potential – where racial and economic disparities have been eliminated, and where the ZIP code you were born in doesn’t shorten life expectancy or quality of life,” Dr. Davis said.

In 2021, Dr. Davis helped Cincinnati Children’s launch HealthVine, a network of pediatric care providers and organizations. It coordinates excellent, equitable, and value-based care and support services for about 135,000 children and their families across Southwest Ohio.

Since the beginning of the pandemic, Dr. Davis has played a key role in coordinating the response of local hospitals. As co-chair of the Regional COVID-19 Steering Committee (March 2020-December 2021) and co-chair of the Hamilton County Test and Protect COVID-19 Project, Dr. Davis helped create policies and procedures designed to ensure the best care for patients and to safeguard hospital workers.

Also under the leadership of Dr. Davis, Cincinnati Children’s ramped up telehealth visits during the pandemic – from 2,000 in all of 2019 to more than 5,000 a week in 2020. Many clinical areas now offer telehealth appointments via the CincyKids Health Connect app. Intended for patients who don’t require an in-person visit, the app provides easier access to care for more kids.

In January 2022, Dr. Davis became vice chair of an international network of more than 140 pediatric hospitals – the Children’s Hospitals’ Solutions for Patient Safety. The network’s efforts have saved more than 18,000 children from serious harm and trimmed an estimated $421.9 million in healthcare costs.

After receiving a bachelor’s degree from Johns Hopkins University in Baltimore in 1984, Dr. Davis earned a medical degree in 1989 from the University of Vermont. He was a medical resident at Pittsburgh Children’s Hospital from 1989-92 and chief resident from 1992-93. Dr. Davis completed a fellowship in pediatric critical care medicine at Johns Hopkins Hospital in 1996.

In 2012, Dr. Davis received a master’s in medical management from the Heinz College at Carnegie Mellon University in Pittsburgh, where he serves on the faculty and teaches leadership development. He earned a master’s in strategic leadership from Michigan State University in 2020.

In 2012, Dr. Davis received a master’s in medical management from the Heinz College at Carnegie Mellon University in Pittsburgh, where he serves on the faculty and teaches leadership development. He earned a master’s in strategic leadership from Michigan State University in 2020.Dr. Davis grew up in Revere, Mass., outside Boston, and worked in the family’s Italian restaurant during high school. His wife, Denise, is a nurse practitioner. They have four children and two grandchildren.

HOWARD CHRISMAN

President & COO

Northwestern Memorial HealthCare

Howard B. Chrisman, MD, MBA, FSIR is the President and Chief Operating Officer of Northwestern Memorial HealthCare, the primary teaching affiliate of Northwestern University Feinberg School of Medicine. Since joining Northwestern Memorial HealthCare in 1997, Dr. Chrisman has been an active clinician and leader who now has primary responsibility for Northwestern Medicine. Northwestern Medicine is comprised of 11 hospitals, over 200 ambulatory and diagnostic sites, and more than 5,500 aligned physicians.

Dr. Chrisman previously served as the Executive Vice President of Clinical Operations for Northwestern Medicine, President of the Northwestern Medical Group, President of the South Region and Palos Health and Vice President of the NMG Regional Medical Practice. Dr. Chrisman has previously served as Interim Chair of four different departments: Radiology, Anesthesia, Pathology and Surgery.

Dr. Chrisman joined Northwestern Medicine in 1997 as faculty and is a Professor of Radiology and Surgery. He received a Bachelor of Science degree from Cornell University, a Doctor of Medicine degree from SUNY Upstate Medical University, and a Master’s of Business degree in Health Care Administration from the University of Colorado. He did his in residency in Radiology at the University of Virginia and his fellowship in Vascular and Interventional Radiology at the Northwestern University Feinberg School of Medicine. Dr. Chrisman has published numerous peer reviewed journal articles and has given multiple scientific and invited oral presentations. Dr. Chrisman is still active clinically with a primary expertise in treating fibroid disease using endovascular techniques.

DR DANIEL DERMAN

Chief Innovation Officer

Northwestern Memorial HealthCare

Dr. Derman is the senior vice president of Administration for Northwestern Memorial HealthCare, overseeing the organization’s Innovation Department and International Department since 2015. As the chief innovation executive for Northwestern Memorial HealthCare, Dr. Derman is responsible for managing the Northwestern Medicine Innovation Center. He has played several key roles in the health system’s response to the COVID-19 pandemic, including co-leading development of testing and vaccine distribution strategies.

In years past. Dr. Derman oversaw the Immediate Care Centers, MyNM Service Center (for staff Human Resources and IT support), and Occupational Health. Dr. Derman is the former president Of Northwestern Memorial Physicians Group, which was acquired by Northwestern Memorial HealthCare in 1995. He earned his medical degree from University of Illinois College of Medicine in 1984. After training in internal medicine from 1984 to 1987 at Northwestern Memorial Hospital, Dr. Derman served as chief medical resident from 1987 to 1988.

PROF. DR. MARTIN E. KREIS

Chief Medical Officer

Charité Universitätsmedizin Berlin

Dr. Martin E. Kreis is a distinguished medical professional with extensive experience in clinical practice and academic research. He is currently the Chief Medical Officer at Charité – Universitätsmedizin Berlin, where he oversees the medical operations of the institution.

Dr. Kreis completed his medical studies at the University of Tübingen in 1993 and subsequently completed his state examination. He began his clinical career as a medical intern at the General Surgery Department/Outpatient Department at Tübingen University Hospital from 1994-1995. He then went on to become a resident physician at the same department from 1995-2001.

During his residency, Dr. Kreis completed a resident rotation in Trauma Surgery at Berufsgenossenschaftliche Unfallklinik Tübingen in 1998-1999 and worked as a resident physician at Städtisches Krankenhaus Sindelfingen, Department for General and Vascular Surgery from 2000-2001. He completed his surgical specialty training in 2001.

Dr. Kreis continued to advance his career as a Senior Physician at Tübingen University Hospital, General Surgery Department/Outpatient Department in 2003, and completed further specialty training in abdominal surgery the same year. He then worked as a Senior Physician at the Department of Surgery, Klinikum Großhadern, LMU Munich from 2004-2012.

In 2012, Dr. Kreis became the W3-Professor and Head of the Department of General, Abdominal and Vascular Surgery at Charité – Universitätsmedizin Berlin, CBF. He also served as the Medical Director of CC08 (CharitéCenter for Surgery) from 2018-2020.

Throughout his career, Dr. Kreis has made significant contributions to the medical field and has been recognized for his outstanding achievements. He is a highly respected medical professional and a sought-after expert in his field.

JAN VAN ACKER

President Emerging Markets Human Health

MSD

Jan Van Acker is SVP at MSD and co-leader of a corporate team responsible for designing and rolling out a new enterprise go-to-market model across R&D, manufacturing and commercial. He is also a board member of MSD’s Global Health Innovation Fund, a US $500M evergreen fund that invests in digital healthcare solutions.

Jan is passionate about making a difference for patients by bringing his skills and experience to bear on complex and important challenges. He is a passionate believer that MSD, as a member of the health care community, can continue to do even more to contribute to improving lives across the world. Driven by the conviction that early adoption of new health technologies results in healthier and more productive societies, and that focusing on patients leads to good business results, he works closely with his teams to find novel ways to bring MSD’s medicines and vaccines to those who need them.

Throughout his career, Jan has actively participated in organizations that promote economic and social development and foster dialogue conducive to improving public health policies. In previous roles he served as chairman of the innovative pharmaceutical industry trade associations in Belgium and Vietnam, and through 2020 he was a board member of the Council of the Americas.

From 2019-2022, he was President of the Emerging Markets where he focused on driving broad access to Keytruda. Prior to this, he was senior vice president and chief marketing officer for MSD’s pharmaceutical business, where he led the successful transformation of the company’s marketing organization. As the president of the Asia-Pacific Region, Jan led that team through a period of significant growth. He also served as managing director for MSD in Vietnam, as managing director for MSD in Belgium and in different other positions in Europe.

Jan earned a degree in Mechanical Engineering from the University of Ghent in Belgium. He also holds master’s degrees from MIT and the MIT Sloan School of Management.

BRIAN GRAGNOLATI

CEO

Atlantic Health System

A healthcare executive with 35 years of experience, Brian Gragnolati serves as President & CEO of New Jersey’s Atlantic Health System. With $4 billion in revenue and 20,000 employees, Atlantic Health System cares for one million patients annually at over 400 sites of care. Gragnolati is former Board Chair of the American Hospital Association (AHA), which represents 5,000 hospitals and healthcare networks across the nation, and a member of the AHA Healthcare Advisory Council to the FBI. He also serves as Executive Partner of Concord Health Partners, an investment firm focused on healthcare innovation. He is a member of the Boards of Directors of Lakeland Bancorp, Inc. (NASDAQ:LBAI) and Lakeland Bank, and serves as a Director of Revology, a technology-enabled healthcare revenue cycle management firm.

A frequent speaker at events such as the Aspen Ideas Health Conference, SXSW, and the International Hospital Federation’s World Hospital Congress, Gragnolati regularly appears on CNBC, MSNBC, and Bloomberg Radio, sharing his passionate advocacy for equitable access and affordability in healthcare. He has been honored as one of Modern Healthcare’s 100 Most Influential People in Healthcare and was selected by Governor Phil Murphy for both the Office of the Governor’s COVID-19 Restart & Recovery Advisory Council and its Professional Advisory Committee.

Brian previously served as Senior Vice President, Community Division of Johns Hopkins Medicine and as President & CEO of Suburban Hospital. He has held executive positions at Pennsylvania’s WellSpan Health, University of Vermont Medical Center, and Baystate Medical Center in Massachusetts. He holds a bachelor’s degree in Health Systems Analysis from the University of Connecticut, an MBA from Western New England College, and an Executive Leadership Certificate from the JFK School at Harvard University.

Dr. Peter Fitzgerald, MD, PhD

Director Of The Cardiovascular Technology Center

Stanford Medical School

Dr. Peter Fitzgerald is Director of the Center for Cardiovascular Technology at Stanford University Medical School, and Co-founder/Managing Partner at Triventures. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor Emeritus in the Departments of Medicine and Engineering at Stanford.

He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. Peter has been principal/founder of 24 healthcare companies in Silicon Valley, has transitioned 18 of these start-ups to medium/large-cap life science companies and remains on several of their advisory boards. He has been a consultant for the FDA for the past 15 years focused on medical technology and more recently, digital health.

Prior, Peter was a co-founding partner of LVP capital in San Francisco, deriving his experience in venture capital from three funds focused on medical device and biotechnology start-ups. Peter is co-founder and managing partner of Triventures and heads the US office.
Peter currently participates on the boards of: Cala Health, Cathworks, Day Zero Diagnostics, FemSelect, Genoox, HealthReveal, V-wave. Past Triventures’ portfolio companies where Peter participated on the boards include: Apica, MST, Orthospace and Zingbox.

Dr. Thomas Lee, MD, MPH

Chief Medical Officer at Press Ganey Associates and Editor-In-Chief at NEJM Catalyst

Press Ganey Associates

Thomas H. Lee is Chief Medical Officer for Press Ganey, where he leads development of strategies for measuring and improving quality of care. He is also a practicing internist/cardiologist at Brigham and Women’s Hospital and on the faculty at Harvard Medical School and Harvard T.H. Chan School of Public Health.

Tom was previously Network President for Partners Healthcare System in Boston. He is Editor in Chief of NEJM Catalyst, serves on the Editorial Board of The New England Journal of Medicine, and is the author of four books, including Chaos and Organization in Healthcare, An Epidemic of Empathy in Healthcare, Eugene Braunwald and the Rise of Modern Medicine, and The Good Doctor. He is a member of the Panel of Health Advisors of the Congressional Budget Office and on the Board of Directors of HealthLeads.

Tom holds a medical degree from Cornell University Medical College and a master’s degree in epidemiology from the Harvard T.H. Chan School of Public Health. He lives in Massachusetts with his wife and three daughters.

Dr. Ernst Kuipers, MD, PhD

President and CEO

Erasmus MC

Ernst Kuipers trained in gastroenterology and hepatology. He was appointed as a member of the Executive Board on 1 December 2012 and has chaired the Board since 15 March 2013. He was educated in the Netherlands (in Groningen, Enschede, Deventer and Amsterdam) and, after obtaining his PhD, spent several years working in Nashville, USA.

He was appointed as a Professor of Gastroenterology and Hepatology and head of our Department of Gastroenterology and Hepatology in 2000, and in 2006 also became head of the Department of Internal Medicine. Among many other things, he was the driving force behind the launch of the national bowel cancer screening program.

The combination of his academic interests and his managerial experience in a wide range of international organizations and committees has given him a broad outlook on both national and international issues, as indeed he needs in order to perform his duties as chair of the Board.

UMANG PATEL

Chief Clinical Innovation Officer

Microsoft

Umang has a proven ability to develop, lead and scale propositions in digital health. He has worked across commercial and public sectors in healthcare both from payor and provider perspective. An NHS Leadership Academy Fellow and practising clinician at Frimley Health, Umang joins us from Babylon Health to become Chief Clinical Information Officer for Microsoft UK.

DR. GEORGE CHERIYAN

CEO

American Mission Hospital

Dr Cheriyan is the CEO and Chief Medical Officer of the American Mission Hospital (AMH) in Bahrain since 2009. He worked as a Neonatologist for over 25 years after obtaining his Medical training in the University of Kerala, and post graduate training in Pediatrics in London at The Hospital for Sick Children, and sub-specialization in Neonatology at the Hospital for Sick Children, in Toronto, Canada.

He worked as a Consultant Neonatologist in the National Health Service In London before moving up to take up a position as a Consultant Neonatologist at Saudi Aramco. He was the Head of Neonatology at the Saudi Aramco Hospital where he worked for 18 years in various capacities of leadership including leading the healthcare quality of Saudi Aramco Healthcare.

He is a trained ‘Improvement Advisor’ in Healthcare quality from the Institute of Healthcare Improvement (IHI) in Boston, MA. He obtained training in Healthcare management at the Harvard Business School, and is an alumni of the Harvard Kennedy School of Government. He has an MBA in leadership from the UK, and his area of interest is in developing a model of non-profit healthcare which is both affordable and of high quality in all economies.

Shlomo Melmed, MB ChB, MACP

Executive Vice President of Academic Affairs and Dean of the Medical Faculty

Cedars-Sinai Medical Center

Dr. Melmed is Dean and Distinguished Professor of Medicine at Cedars-Sinai Medical Center. A recipient of numerous awards from the Royal Society of Medicine, the Endocrine Society and the Pituitary Society, his NIH-funded laboratory is devoted to pathogenesis and treatment of pituitary tumors.

He serves as editor of major endocrinology textbooks used worldwide, was President of the International Society of Endocrinology, and is a Director of the California Institute of Regenerative Medicine. He has shepherded academic programs with a sustained impact on the practice of medicine by his clinical leadership and major translational discoveries.

​​

Prof. Lee Chien Earn

Chief Executive Officer

SingHealth

Prof Lee is currently the Deputy Group Chief Executive Officer, Regional Health System, SingHealth that seeks to enable the population in Eastern Singapore to keep well, get well and live well. He also Chairs the Planning Committee for the upcoming Eastern General and Community Hospitals. He was previously the Chief Executive Officer of Changi General Hospital, a 1000 bed acute teaching hospital. Prior appointments included senior leadership positions in the Ministry of Health Singapore where he was involved in the strategic development and improvement of healthcare services as well as health regulation and finance.

Prof Lee is a public health specialist who received his medical degree and Masters of Medicine (Public Health) from the National University of Singapore. He is currently a Clinical Professor with the Duke-NUS Medical School and Adjunct Professor in the Saw Swee Hock School of Public Health, National University of Singapore, and the Singapore University of Technology and Design.  He was also a member of international committees such as International Steering Committee, WHO Collaborating Centre for Patient Safety; Steering Committee, Asia-Pacific Observatory on Health Systems and Policies; Joint Commission International Standards Advisory Panel.

Locally Prof Lee was the Chairman of the Singapore Healthcare Improvement Network (SHINE), a network of more than 40 public, private and voluntary organisations committed to accelerate the pace and scale of improvement in Singapore to meet the needs of patients and families, with the best patient outcome. Prof Lee co-edited Singapore’s Health Care System: What 50 Years Have Achieved (2015) and contributed the chapter on Strategies for Health Services in the Oxford Textbook of Global Public Health (6th edition).

​​

Dr. Lucie Opatrny,
MDCM, MHCM, M.Sc.

President & Executive Director

McGill University Health Centre

 

Dr. Opatrny became the president and executive director of the McGill University Health Centre since January 30, 2023. Previously, from 2018, she was assistant deputy minister, Québec Ministry of Health and Social Services (academic, medical, nursing and pharmaceutical affairs) and before that a director of professional services. She holds a MDCM and Master’s degree in Epidemiology and Biostatistics from McGill and a Master’s degree in Health Care Management and Diploma in Advanced Negotiation from Harvard.